Skip to main content
Log in

Preparation and characterisation of lornoxicam solid dispersion systems using hot melt extrusion technique

  • Research Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

The aim of the research study was to investigate the ability of Soluplus® and surfactant individually as well as in combination to improve the solubility, subsequently the dissolution profile of lornoxicam (LORX). A laboratory size single screw rotating extruder with temperature and speed control parameters employed during hot melt extrusion (HME) processing of LORX along with polymer-surfactant blends. Soluplus® used as primary solubilizing agent for preparing solid dispersion (SD). Along with Soluplus® different concentrations of surfactants such as PEG 400, Lutrol F127, Lutrol F68 were used to solve the permeability issues related to LORX. Encapsulation of LORX particles inside the molten matrix of polymer-excipient blend was confirmed by DSC, XRD and FT-IR. Drug excipient microscopic interaction was further confirmed by scanning electron microscopy (SEM). Depending upon the ratio of the polymer and surfactants used, the solubility of the hot melt extruded LORX was improved and found to be in the range 35–86 μg/ml (actual aqueous solubility of LORX was found to be 0.0083 μg/ml). Dissolution profile of the extruded SD was improved and was found to be in the range of 98–104 % within 20 min (actual dissolution profile of LORX was found to be 8 % at the end of 1 h). SEM and Raman images suggest the formation of amorphous dispersion systems. SD was subjected to stability studies as per ICH guidelines and found to be stable after 6 months when analyzed by HPLC. SD prepared from HME significantly improves the solubility and dissolution profile of LORX—a BCS class II drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  • Almeida A, Saerens L, De Beer T, Remon JP, Vervaet C (2012) Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Int J Pharm 439:223–229. doi:10.1016/j.ijpharm.2012.09.037

    Article  CAS  PubMed  Google Scholar 

  • Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG (2008) Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech 9:563–570

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bramhane DM, Saindane NS, Vavia PR (2011) Inclusion complexation of weakly acidic NSAID with β-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component. J Incl Phenom Macrocycl Chem 69:453–460

    Article  CAS  Google Scholar 

  • Breitenbach J (2002) Melt extrusion: from process to drug delivery technology. Eu J Pharm Biopharm 54:107–117

    Article  CAS  Google Scholar 

  • Burugu R (2011) Stability-indicating LC method for analysis of lornoxicam in the finished dosage form. Int J Pharm Pharm Sci 3:318–322

    Google Scholar 

  • Chemete SZ (2012) A factorial study on enhancement of solubility and dissolution rate of lornoxicam employing Hp-β-cyclodextrin and surfactants. Int J Pharm Sci Res 3(7):2252–2256

    Google Scholar 

  • Chokshi RJ, Malick WA (2007) Improving the dissolution rate of poorly water soluble drug by SD and solid solution. Drug Deliv 14(1):33–45

    Article  CAS  PubMed  Google Scholar 

  • Forster A, Hempenstall J, Tucker I, Rades T (2001) Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 226:147–161

    Article  CAS  PubMed  Google Scholar 

  • Fu J, Zhang L (2010) Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Technol 204:214–221

    Article  CAS  Google Scholar 

  • Fule RA, Amin PD (2013a) Artemether-soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristics. J Pharm 1:1–15

    Google Scholar 

  • Fule RA, Amin PD (2013b) Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation. J Pharm Inv 43:305–321

    Article  CAS  Google Scholar 

  • Gavin PA, Osama AD (2010) Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharm 62:1580–1590

    Article  Google Scholar 

  • Greenhalgh DJ, Timmins PY (1999) Solubility parameters as predictors of miscibility in SD. J Pharm Sci 88:1182–1190

    Article  CAS  PubMed  Google Scholar 

  • Higuchi T, Connors K (1965) Phase-solubility techniques. Adv Anal Chem Instrum Tech 4:117–130

    CAS  Google Scholar 

  • Jung JY (1999) Enhanced solubility and dissolution rate of itraconazole by a SD technique. Int J Pharm 187:209–218

    Article  CAS  PubMed  Google Scholar 

  • Kalogeras IM (2011) A novel approach for analysing glass-transition temperature vs. composition patterns: application to pharmaceutical compound + polymer systems. Eur J Pharm Sci 42:470–483

    Article  CAS  PubMed  Google Scholar 

  • Kharwade M (2012) Solubility behavior of lornoxicam in binary solvents of pharmaceutical interest. J Sol Chem 41(8):1364–1374

    Article  CAS  Google Scholar 

  • Konno H, Taylor LS (2006) Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 95:2692–2705

    Article  CAS  PubMed  Google Scholar 

  • Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using SD. Eur J Pharm Biopharm 50:47–60

    Article  CAS  PubMed  Google Scholar 

  • Linn M (2012) Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro. Eu J Pharm Sci 45:336–343

    Article  CAS  Google Scholar 

  • Maniruzzaman M, Morgan DJ, Douroumis D (2013) Drug–polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 443:199–208

    Article  CAS  PubMed  Google Scholar 

  • Modi A (2006) Enhancement of dissolution profile by solid dispersion (Kneading) technique. AAPS PharmSciTech 7(3):1–6

    Article  Google Scholar 

  • Osama AA, David SJ (2012) Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods. J Pharm Sci 101:200–213

    Article  Google Scholar 

  • Pan RN (2000) Enhancement of dissolution and bioavailability of Piroxicam in solid dispersion system. Drug Dev Ind Pharm 26(9):989–994

    Article  CAS  PubMed  Google Scholar 

  • Prajapati P (2012) Azeotropic mixture used for development and validation of lornoxicam in bulk and its tablet dosage form by spectrophotometric method. J Pharm Anal 2:306–309

    Article  CAS  Google Scholar 

  • Saerens L, Dierickx L, Lenain B (2011) Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. Eur J Pharm Biopharm 77:158–163

    Article  CAS  PubMed  Google Scholar 

  • Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Jayachandra BR (2012) Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement. J Pharm Sci 101:3456–3464

    Article  CAS  PubMed  Google Scholar 

  • Serajuddin Abu TM (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharma Sci 88:1058–1066

    Article  Google Scholar 

  • Singla K (2012) Preparation and evaluation of lornoxicam niosomal gel. Int Res J Pharm 3(4):378–383

    CAS  Google Scholar 

  • Vasconcelos T, Sarmento B (2007) SD as strategy to improve oral bioavailability of poorly water soluble drugs. Drug Discov Today 12:1068–1075

    Article  CAS  PubMed  Google Scholar 

  • Xie Y (2009) Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L. AAPS PharmSciTech 10(2):631–640

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG (2012) Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm 422:202–210

    Article  CAS  PubMed  Google Scholar 

  • Yang J, Gray K, Doney J (2010) An improved kinetics approach to describe the physical stability of amorphous SD. Int J Pharm 384:24–31

    Article  CAS  PubMed  Google Scholar 

  • Zsombor KN, Attila B (2012) Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci 101:322–332. doi:10.1002/jps.22731

    Article  Google Scholar 

Download references

Acknowledgments

The authors are thankful to Alkem Pharmaceuticals Ltd., India for providing the gift sample of LORX, BASF Ltd. Mumbai for the gift sample of Soluplus®, Lutrol® F127 and Lutrol® F68. The author is also thankful to UGC (SAP) for providing the research fellowship and Institute of Chemical Technology, ELITE status (Mumbai, India) for providing all facilities and guidance.

Conflict of interest

None.

Compliance with ethical requirements

This article dose not contain any studies with human and animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ritesh Fule.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fule, R., Meer, T., Amin, P. et al. Preparation and characterisation of lornoxicam solid dispersion systems using hot melt extrusion technique. Journal of Pharmaceutical Investigation 44, 41–59 (2014). https://doi.org/10.1007/s40005-013-0099-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-013-0099-7

Keywords

Navigation